πŸ‡ΊπŸ‡Έ FDA
Patent

US 10070632

Rodents having a humanized TMPRSS gene

granted A61KA61K48/00

Quick answer

US patent 10070632 (Rodents having a humanized TMPRSS gene) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K48/00